Oireachtas Joint and Select Committees
Wednesday, 21 November 2018
Joint Oireachtas Committee on Health
Evaluating Orphan Drugs: Discussion (Resumed)
9:00 am
Mr. Shaun Flanagan:
Yes, but to clarify, that is if there is a budget impact. If money is being spent, it is the director general, the directorate and the HSE senior leadership team that must sign off on it. There are some medicines, however, for which the net cost is not additional, and we accelerate the process for them.